PERCUTANEOUS CORONARY INTERVENTION

This study compares a new software tool called FFRangio, which uses 3D X-ray images to assess heart artery blockages, against the standard invasive pressure wire method. About 1,924 adults with coronary artery disease are participating. The goal is to see if the software-guided t…

This study looks at how well the GENOSS stent works in real-world patients who have had a heart attack or unstable chest pain (acute coronary syndrome). Researchers are tracking heart-related events like death, heart attacks, and the need for repeat procedures. The study involves…

This study tests whether a blood test can help doctors safely lower the dose of strong blood thinners (P2Y12 inhibitors) in people who recently had a heart attack or stent. The goal is to reduce bleeding complications without raising the risk of another heart attack or stroke. Ab…

This study is testing a new type of stent (a small mesh tube) coated with a drug that slowly releases to keep heart arteries open. The stent uses a special coating that dissolves over time, which may reduce long-term risks. About 1,000 adults with coronary artery disease who need…

This study is tracking 1000 adults with multivessel coronary artery disease who received a special drug-coated stent called GENOSS® DES. The stent slowly releases sirolimus to help prevent the artery from narrowing again. Researchers are monitoring safety and effectiveness over t…

This study compares a robot-assisted heart procedure to the standard manual approach in 80 adults with stable angina who need a stent. The robot, called AVIAR, helps guide catheters and balloons. Researchers will check if the robot is as safe and effective, and if it reduces radi…

This study follows 2,600 adults with coronary heart disease and depression who received a stent. Researchers track major heart problems like heart attacks or death over one year to find what predicts these events. The goal is to better understand the link between depression and h…

This registry studies how genetic information can help doctors choose the best antiplatelet medication for people who have had a heart stent procedure. Over 1,600 participants will provide DNA samples and be followed for 12 months to track heart events and bleeding. The goal is t…

This study looks at 500 women with chest pain to compare two tests used during heart catheterization—FFR and iFR—to see which better predicts future heart problems like heart attacks or strokes. Participants will be followed for 5 years. The goal is to improve how doctors decide …